We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
High Smac/DIABLO expression is associated with early local recurrence of cervical cancer.
- Authors
Arellano-Llamas, Abril; Garcia, Francisco J.; Perez, Delia; Cantu, David; Espinosa, Magali; De la Garza, Jaime G.; Maldonado, Vilma; Melendez-Zajgla, Jorge
- Abstract
Background: In a recent pilot report, we showed that Smac/DIABLO mRNA is expressed de novo in a subset of cervical cancer patients. We have now expanded this study and analyzed Smac/DIABLO expression in the primary lesions in 109 cervical cancer patients. Methods: We used immunohistochemistry of formalin-fixed, paraffin-embedded tissue sections to analyze Smac/DIABLO expression in the 109 primary lesions. Seventy-eight samples corresponded to epidermoid cervical cancer and 31 to cervical adenocarcinoma. The median follow up was 46.86 months (range 10-186). Results: Smac/DIABLO was expressed in more adenocarcinoma samples than squamous tumours (71% vs 50%; p = 0.037). Among the pathological variables, a positive correlation was found between Smac/DIABLO immunoreactivity and microvascular density, a marker for angiogenesis (p= 0.04). Most importantly, Smac/DIABLO immunoreactivity was associated with a higher rate of local recurrence in squamous cell carcinoma (p = 0.002, log rank test). No association was found between Smac/DIABLO and survival rates. Conclusion: Smac/DIABLO expression is a potential marker for local recurrence in cervical squamous cell carcinoma patients.
- Subjects
CERVIX uteri; GENE expression; TUMORS; CANCER; ONCOLOGY
- Publication
BMC Cancer, 2006, Vol 6, p256
- ISSN
1471-2407
- Publication type
Article
- DOI
10.1186/1471-2407-6-256